Navigation Links
Afid Therapeutics Obtains Positive Evaluation of its Triple Mode,Viral Sequestration Agents

/p>

CONTACT: Dr. Rawle I. Hollingsworth +1-517-336-4663, Fax +1-517-324-1912, rih@afidtherapeutics.com

Web site: http://www.afidtherapeutics.com/

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care

Post Your Comments:
(Date:11/6/2009)...-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nas...y, November 10, 2009 at 8:30 a.m. EST to discuss t...ss outlook for the remainder of 2009. Ron Bentsur...t the call. Keryx will announce its financial res...ed prior to the call. ,, In order to participat...
(Date:11/6/2009)...FirstCall/ -- Caraco Pharmaceutical Laboratories, ...methamine ophthalmic solution, 0.5% following a fi...ion (FDA) for Sun Pharma,s Abbreviated New Drug Ap...c solution on the first day following patent expir...ly equivalent to Acular® Ophthalmic Solution,...
(Date:11/5/2009)... 5 Transcept Pharmaceuti...tical company focused on the development and comme...important therapeutic needs in the field of neuros... teleconference with management to discuss third q...r 12, 2009, at 5:00 p.m. Eastern Standard Time. F...
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2Gene findings revealing reasons for neuroblastoma risk 49275 1Gene findings revealing reasons for neuroblastoma risk 49275 2Study supports validity of test that indicates widespread unconscious bias 49273 1Study supports validity of test that indicates widespread unconscious bias 49273 2Roux en Y weight loss surgery raises kidney stone risk 49271 1Roux en Y weight loss surgery raises kidney stone risk 49271 2
(Date:11/8/2009)...ADELPHIA, Nov. 8 The Am...he prevention and wellness provisions in the healt..., "With passage of this bill, the House takes impo...important insurance reforms and moving our health ...to one that focuses on keeping people healthy," sa...
(Date:11/8/2009)...er Costs and Crushing Taxes Nail Nation,s Job Crea...re/ -- In response to U.S. House passage of the he...ntrepreneurship Council (SBE Council) president &a...ent: ,, "Make no mistake, those voting for H.R...ith higher costs and crushing taxes and penalties....
(Date:11/8/2009)... Freeze-drying of biopharmaceutical...ga, Ontario facility. , ...lner, President and CEO of Therapure Biopharma Inc...ery of a commercial scale pharmaceutical grade fre...eze drying (lyophilization) available for contract...
(Date:11/8/2009)...ion,s largest network of Hispanic health advocates...orm in 2009 ,, WASHINGTON, Nov. 7 /PRNewswire-...tatives showed they have heard the voice of Americ... for America Act. Now the Senate must deliver, wit...re reform," said Dr. Jane L. Delgado, President an...
(Date:11/8/2009)...P Praises House Passage of Health Care Reform Bill...icare, improve coverage for all Americans ,, C...he United States House of Representatives passed b...egislation that would strengthen Medicare for seni...that prices millions of Americans out of affordabl...
Breaking Medicine News(10 mins):Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3
...at the cox-2 inhibitor celecoxib, a common pain re...k of the most common cause of brain damage in pre...p blood vessels in a part of the brain that in pre...lastingly affected by cerebral palsy, mental retar...
...e risk of a type of kidney malignancy called renal...hers at Brigham and Women's Hospital in Boston fou...alcoholic beverage a day were about 30 percent les...nd other researchers reviewed data from 12 studies...
...s generally suffer in silence, cough up more money...th mixed results. And here comes the news tha...ring warranty on its workmanship, charging a flat ...nd the insurer another bill. Well the Geisin...
... a health authority in St. John's, Canada, has apo...tests that may have affected the care of hundreds...the Eastern Health Regional Authority agreed that ... that we didn't simply refer to it earlier,' Tille...
...of Cincinnati have developed a model that could im... helping physicians combine current clot-busting ...othermia. It is already known that lowerin...pproved stroke medication is an enzyme called tiss...
...s of the four sick public sector pharmaceutical an...overnments , the railways and the armed forces hav...hem profit making units. According to the ... Hindustan Organic Chemicals Limited have been rev...
Other Medicine News:Health News:Common Pain Killer may Reduce the Risk of Brain Damage in Premature Babies 2Health News:Common Pain Killer may Reduce the Risk of Brain Damage in Premature Babies 3Health News:US Hospital Group Offers Warranty on Surgeries 2Health News:US Hospital Group Offers Warranty on Surgeries 3Health News:Faulty Hormone Tests Compromised Healthcare Of Breast Cancer Patients 2Health News:Researchers Develop Model That Aids in Treating Stroke Patients 2Health News:Government Hospitals to the Rescue of Loss-making Pharma Companies 2
Troponin I - Rapid Test
...or many patients with a diseased heart, the only t...t transplant. However, donor organs are not always...le die while they are on the waiting list for a do... devices (VAD) can save the life of a patient. On ...
...nstaTest AFP is an immunochromatographic in vitro ...n human serum. AFP is a protein with molecular mas...entration in serum is below 9 ng/mL; higher concen... testicular and presacral teratocarcinomas, and ot...
Roche/STAGO STA Compact
Medicine Products: